Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Angiopoietin 2 (ANGPT2) is a proangiogenic cytokine whose expression is often upregulated by endothelial cells in tumors. Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs). Genetic depletion of TEMs markedly reduces tumor angiogenesis in various tumor models, emphasizing their essential role in driving tumor progression. Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro. We now show that TEMs also express higher levels of IL-10 than TIE2− macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4+ T cells to CD8+ T cells, and promotes the expansion of CD4+CD25highFOXP3+ Tregs. Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors. Taken together, our data suggest that ANGPT2-stimulated TEMs represent a novel, potent immunosuppressive force in tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, ANG2 increases leukocyte–endothelial interactions via upregulation of adhesion molecules, thereby facilitating the recruitment of MDSCs29, Treg cells30, and TIE2-expressing monocytes that induce immunosuppression31”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [30]
In the citing paper
“Thirdly, despite without direct influence on T cells, ANGPT2 recruits Tie-2-expressing monocytes, enhances the differentiation towards M2-like macrophages, and upregulates the expression of IL-10 [94–97].”
From Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960 · cited 1×
“IFN-g and IL-4 were used as controls in coculture assays as they induce an M1/immunostimulatory and M2/immunosuppressive phenotype in monocytes, respectively (9, 10, 16).”
MethodControl of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Cited by
Items 101–200 of 232
Krijgsman, D., Vries, N. L. D., Andersen, M. N., Skovbo, A., Tollenaar, R. A. �. �., Møller, H. J., Hokland, M., & Kuppen, P. J. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165925 · Cited by 45
Baek, A., Kim, Y., Lee, J. W., Lee, S. C., & Cho, S.-R. (2018) · Cell Transplantation · doi:10.1177/0963689718804130 · Cited by 39
Immune Cells as a Source and Target of Angiogenic and Lymphangiogenic Factors
Loffredo, S., Staiano, R. I., Granata, F., Genovese, A., & Marone, G. (2013) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000353316 · Cited by 38
Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
Dong, Z., Chen, J., Yang, X., Zheng, W., Wang, L., Fang, M., Wu, M., Yao, M., & Yao, D. (2018) · Oncotarget · doi:10.18632/oncotarget.24061 · Cited by 40
Endothelial CD34 expression and regulation of immune cell response in-vitro
Arakélian, L., Lion, J., Churlaud, G., Bargui, R., Thierry, B., Mutabazi, E., Bruneval, P., Alberdi, A. J., Doliger, C., Veyssière, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40622-7 · Cited by 40
Doig, T. N., Hume, D. A., Theocharidis, T., Goodlad, J. R., Gregory, C. D., & Freeman, T. C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-469 · Cited by 42
Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
Erbani, J. M., Boon, M., & Akkari, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.003 · Cited by 37
Kim, J., de Sampaio, P. C., Lundy, D. M., Peng, Q., Evans, K. W., Sugimoto, H., Gagea, M., Kienast, Y., do Amaral, N. S., Rocha, R. M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90733 · Cited by 36
Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
Ho, R. L. Y., & Ho, I. A. W. (2021) · Cancers · doi:10.3390/cancers13153686 · Cited by 34
Macrophages in Cancer and Infectious Diseases: The ‘Good‘ and the ‘Bad‘
Porta, C., Riboldi, E., Totaro, M. G., Strauss, L., Sica, A., & Mantovani, A. (2011) · Immunotherapy · doi:10.2217/imt.11.116 · Cited by 38
Role of angiopoietin-2 in inflammatory autoimmune diseases: A comprehensive review
Wu, Q., Xu, W., & Huang, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106223 · Cited by 32
Le, C. T., Laidlaw, G., Morehouse, C. A., Naiman, B. M., Brohawn, P. Z., Mustelin, T., Connor, J. R., & McDonald, D. M. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.010 · Cited by 34
Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment
Cao, L., Meng, X., Zhang, Z., Liu, Z., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01201-z · Cited by 32
Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment
Quaresmini, D., & Guida, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584903 · Cited by 30
Asiry, S., Kim, G., Filippou, P. S., Sanchez, L. R., Entenberg, D. R., Marks, D. K., Oktay, M. H., & Karagiannis, G. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654877 · Cited by 30
Chandel, S., Sathis, A., Dhar, M., Giri, H., Nathan, A. A., Samawar, S. K. R., Gupta, A., Gopal, J., Ranjani, H., Mohan, V., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.06.016 · Cited by 30
Al‐Janabi, H., Moyes, K., Allen, R. J., Fisher, M., Crespo, M., Gürel, B., Rescigno, P., Bono, J. S. D., Nunns, H., Bailey, C., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009368 · Cited by 27
Self-citationXu, Q., & Shao, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1487610 · Cited by 27
Angiogenic factors in chronic lymphocytic leukemia
Xia, Y., Lu, R., & Li, J. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.05.021 · Cited by 26
Im, J. H., Tapmeier, T., Balathasan, L., Gal, A., Yameen, S., Hill, S., Smart, S., Noterdaeme, O., Kelly, M., Brady, M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27677 · Cited by 25
Toghraie, F. S., Bayat, M., Hosseini, M. S., & Ramezani, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01051-y · Cited by 25
Kowalski, E., Soliman, E., Kelly, C., Basso, E. K. G., Leonard, J. W., Pridham, K. J., Ju, J., Cash, A., Hazy, A., de Jager, C., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156319 · Cited by 26
An, Y., Pu, N., Jia, J.-B., Wang, W., & Liu, L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188958 · Cited by 26
He, Y., Wang, C., Yao, Y., Qian, J., Song, K., Sun, Q., & Zhou, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143657 · Cited by 26
Novel prognostic scoring system for diffuse large B-cell lymphoma
Zhao, P., Zang, L., Zhang, X., Chen, Y., Yue, Z., Yang, H., Zhao, H., Yu, Y., Wang, Y., Zhao, Z., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7966 · Cited by 27
Self-citationLi, B., Wang, S., Li, C., Guo, M., Xu, Y., Sun, X., Yu, J., & Wang, L. (2019) · Journal of Cancer · doi:10.7150/jca.30478 · Cited by 26
Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer
Wang, G., Li, X., Tian, W., Wang, Y., Wu, D., Sun, Z. S., & Zhao, E. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22257 · Cited by 23
Dopheide, J. F., Geißler, P., Rubrech, J., Trumpp, A., Zeller, G. C., Bock, K., Dorweiler, B., Dünschede, F., Münzel, T. F., Radsak, M. P., et al. (2015) · Angiogenesis · doi:10.1007/s10456-015-9489-y · Cited by 26
Escobar, G., Gentner, B., Naldini, L., & Mazzieri, R. (2014) · OncoImmunology · doi:10.4161/onci.28696 · Cited by 26
Macrophage-mediated response to hypoxia in disease
Murdoch, C., Tazzyman, S. J., Harrison, J., Yeomans, J., & Muthana, M. (2014) · Hypoxia · doi:10.2147/hp.s49717 · Cited by 24
Self-citationMarguier, A., Laheurte, C., Lecoester, B., Malfroy, M., Boullerot, L., Renaudin, A., Seffar, E., Kumar, A., Nardin, C., Aubin, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932298 · Cited by 21
Albain, K. S., Yau, C. S. F., Petricoin, E. F., Wolf, D. M., Lang, J. E., Chien, A. J., Haddad, T. C., Forero, A., Wallace, A. M., Kaplan, H. G., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2256 · Cited by 21
Self-citationSridharan, V., Margalit, D. N., Lynch, S. A., Severgnini, M., Hodi, F. S., Haddad, R. I., Tishler, R. B., & Schoenfeld, J. D. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0138-9 · Cited by 21
Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
Wu, M., Shi, Y. K., Zhu, L., Chen, L., Zhao, X., & Xu, C. S. (2022) · Life · doi:10.3390/life12081225 · Cited by 22
Anti-angiogenesis immunotherapy
Schoenfeld, J. D., & Dranoff, G. (2011) · Human Vaccines · doi:10.4161/hv.7.9.16407 · Cited by 21
Yu, X., Sha, J., Shao, X., Qin, S., Conrad, P., Ghosh, S. K., Weinberg, A., & Ye, F. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1196303 · Cited by 20
Ziegler, J., Zalles, M., Smith, N., Saunders, D., Lerner, M. R., Fung, K., Patel, M. M., Wren, J. D., Lupu, F., Battiste, J. D., et al. (2019) · Europe PMC (PubMed Central) · Cited by 23
Analysis of Tie2-Expressing Monocytes (TEM) in Patients With Colorectal Cancer
Goede, V., Coutelle, O., Shimabukuro‐Vornhagen, A., Holtick, U., Neuneier, J., Koslowsky, T. C., Weihrauch, M. R., von Bergwelt‐Baildon, M., & Hacker, U. T. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.636114 · Cited by 20
Smadja, D. M., Berkane, Y., Bentounes, N. K., Rancic, J., Cras, A., Pinault, C., Ouarné, M., Paucod, E., Rachidi, W., Lellouch, A. G., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-09973-9 · Cited by 20
Kapiainen, E., Kihlström, M. K., Pietilä, R. S., Kaakinen, M., Ronkainen, V., Tu, H., Heikkinen, A., Devarajan, R., Miinalainen, I., Laitakari, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-1904 · Cited by 19
Mooi, J. K., Chionh, F. J. M., Savas, P. S., Duarte, J. D. G., Chong, G., Brown, S. C., Wong, R., Price, T. J., Wann, A., Skrinos, E., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2714 · Cited by 16
Shi, Y., Li, Y., Wu, B., Zhong, C., Lang, Q., Liang, Z., Zhang, Y., Lv, C., Han, S., Yu, Y., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108968 · Cited by 17
Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases
Luo, A.-J., Chang, F., & Lin, S. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.001 · Cited by 20
Sirolimus for kaposiform hemangioendothelioma: Potential mechanisms of action and resistance
Qiu, T., Xiang, S., Zhou, J., Yang, M. J., Lan, Y., Zhang, X., Gong, X., Zhang, Z., & Ji, Y. (2024) · International Journal of Cancer · doi:10.1002/ijc.35207 · Cited by 17
Tang, H., Ma, H., Peng, F., Bao, Y., Hu, X., Wang, J., Xu, Y., & Chen, M. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.796 · Cited by 17
Remodeling of Tumor Stroma and Response to Therapy
Johansson, A., & Ganß, R. (2012) · Cancers · doi:10.3390/cancers4020340 · Cited by 19
Oudard, S. M., Benhamouda, N., Escudier, B. J., Ravel, P., Tran, T., Levionnois, É., Négrier, S., Barthélémy, P., Berdah, J. F., Gross‐Goupil, M., et al. (2021) · Cells · doi:10.3390/cells11010017 · Cited by 17
Steinberger, K. J., Forget, M. A., Bobko, A. A., Mihalik, N. E., Gencheva, M., Roda, J. M., Cole, S. L., Mo, X. M., Hoblitzell, E. H., Evans, R., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000185 · Cited by 16
Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful
Szulc-Kiełbik, I., & Kiełbik, M. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_4 · Cited by 14
Targeting tumor-associated macrophages to reverse antitumor drug resistance
Li, S., Sheng, J., Zhang, D., & Qin, H. (2024) · Aging · doi:10.18632/aging.205858 · Cited by 16
Ruan, L., Zhang, S., Chen, X., Liang, W., & Xie, Q. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153956 · Cited by 14
The Angiopoietin—Tie System: Common Signaling Pathways for Angiogenesis, Cancer, and Inflammation
Reiss, Y., Scholz, A., & Plate, K. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2907-8_13 · Cited by 18
Self-citationLi, Y., Yang, L., & Zd, L. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104883 · Cited by 14
Zhang, B., Yin, X., Li, J., Ren, C., Liu, W., Liu, G., & Lu, P. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107972 · Cited by 13
Xue, R., Sheng, Y., Duan, X., Yang, Y., Ma, S., Xu, J., Wei, N., Shang, X., Li, F., Wan, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33381 · Cited by 13
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Bhatia, D., Dolcetti, R., & Mazzieri, R. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03359-x · Cited by 13
Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse
Moamin, M. R., Allen, R. J., Woods, S. L., Brown, J. E., Nunns, H., Juncker‐Jensen, A., & Lewis, C. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291643 · Cited by 13
Self-citationImmunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
Pour, S. R., Morikawa, H., Kiani, N. A., Gómez-Cabrero, D., Hayes, A., Zheng, X., Pernemalm, M., Lehtiö, J., Mole, D. J., Hansson, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00051 · Cited by 11
Mikulková, Z., Manukyan, G. P., Turcsányi, P., Kudělka, M., Urbanová, R., Savara, J., Ochodková, E., Brychtová, Y., Molinský, J., Šimkovič, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79121-4 · Cited by 11
The strange Microenvironment of Glioblastoma
Brisson, L., Geraldo, L. H., Bikfalvi, A., & Mathivet, T. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.03.007 · Cited by 11
Tie2-expressing monocytes/macrophages promote angiogenesis in chronically ischaemic brain tissue
Tai, C., Ling, C., Yang, Y., Zhang, B., Sun, J., Mo, N., Sun, T., Huang, L., Yao, C., Wang, H., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01401-1 · Cited by 11
Hélaine, C., Ferré, A. E., Leblond, M. M., Pérès, E. A., Bernaudin, M., Valable, S., & Petit, E. (2020) · Cancers · doi:10.3390/cancers12123585 · Cited by 10
Liu, J., Wu, L., Liu, Z., Seery, S., Li, J., Gao, Z., Yu, J., & Meng, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671912 · Cited by 9
Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages
Ehrentraut, H., Weisheit, C. K., Scheck, M., Frede, S., & Hilbert, T. (2018) · Journal of Inflammation · doi:10.1186/s12950-018-0188-5 · Cited by 10
Lei, L., Long, J., Chen, C., Zheng, B., Lin, X., Fang, P., Chen, M., Jiang, X., Wang, Y., & Wang, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117574 · Cited by 8
Skiba, W., Suszczyk, D., Pawłowska, A., Włodarczyk, K., Pańczyszyn, A., & Wertel, I. (2022) · Cells · doi:10.3390/cells11233851 · Cited by 9
Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression
Brennecke, P., Allavena, P., Laface, I., Mantovani, A., & Bottazzi, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_2 · Cited by 10
Pérez-Regalado, S., León, J., & Feriche, B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-03918-1 · Cited by 9
Sesti, F. F., Puliani, G., Feola, T., Campolo, F., Sciarra, F., Hasenmajer, V., Lenzi, A., Faggiano, A., Isidori, A. M., Venneri, M. A., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03257-8 · Cited by 6
Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients
Woś, J., Chocholska, S., Kowalska, W., Tomczak, W., Szymańska, A., Karczmarczyk, A., Szuster‐Ciesielska, A., Wojciechowska, A., & Bojarska-Junak, A. A. (2021) · Cancers · doi:10.3390/cancers13112817 · Cited by 6
Transcriptome differences in adipose stromal cells derived from pre- and postmenopausal women
Xie, Y., Fang, B., Liu, W., Li, G., Huang, R., Zhang, L., He, J., Zhou, S., Liu, K., & Li, Q. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01613-x · Cited by 7
The possible dual role of Ang-2 in the prognosis of pancreatic cancer
Juusola, M., Kaprio, T., Mustonen, H. K., Hagström, J., Saharinen, P., Haglund, C. H., & Seppänen, H. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-45194-0 · Cited by 5
Angiopoietins and TIE Receptors in Lymphangiogenesis and Tumor Metastasis
He, Y. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_43 · Cited by 5
Steinberger, K. J., Forget, M. A., Bobko, A. A., Mihalik, N. E., Gencheva, M., Roda, J. M., Cole, S. L., Mo, X. M., Hoblitzell, E. H., Evans, R., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001134 · Cited by 5
Yasinoglu, S. A., Novella-Rausell, C., Wisse, L. E., Dijkstra, K. L., Mahfouz, A. E., Baelde, H. J., & Peters, D. J. M. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000894 · Cited by 4
The interaction between end-metabolites and immune escape
Zhu, T., & Wang, G. (2022) · Oncology and Translational Medicine · doi:10.1007/s10330-022-0573-3 · Cited by 4
Chou, M.-Y., & Yang, M. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102353 · Cited by 6
Peripheral Immune Response Following Traumatic Brain Injury
Hazy, A., Kowalski, E., Groot, N., & Theus, M. H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93597 · Cited by 4
Bosco, M. C., & Varesio, L. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_5 · Cited by 4
Chen, Y., CHEN, P.-Y., Chang, C., Huang, C., Yu, C.-C., Lin, V. C.-H., CHANG, H.-H., Lu, T., Huang, S., & Bao, B. (2025) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20551 · Cited by 3
Self-citationSharif, P. M., Khoshbin, A. P., Nasrollahzadeh, E., Keshavarz‐Fathi, M., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00003-7 · Cited by 8
Dou, H., Brandon, N. R., Koper, K., & Xu, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00397 · Cited by 3
Rodríguez-Muñoz, Y., Martín‐Vílchez, S., López‐Rodríguez, R., Hernández‐Bartolomé, Á., García-Buey, L., Borque, M. J., Moreno‐Otero, R., & Sanz-Cameno, P. (2013) · Liver International · doi:10.1111/liv.12125 · Cited by 3
Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma
Herman, M., Lok, B. H., Gallinger, S., Dawson, L. A., Kim, R. H., Cheng, D., Paton, T., Bucur, R., Patel, D., Fazelzad, R., et al. (2023) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-22 · Cited by 2
Angiopoietins and TIE Receptors in Lymphangiogenesis and Tumor Metastasis
He, Y. (2019) · Springer eBooks · doi:10.1007/978-3-319-31215-6_43-1 · Cited by 2
Antiangiogenic drugs as chemosensitizer in melanoma
Quaresmini, D., & Guida, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90190-1.00003-2 · Cited by 1
Yang, Y., Jiang, L., Li, K., Zhang, G., Wang, J., & Li, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1735406 · Cited by 1
Privitera, L., Alberti, P., Senica, S. O., Neville, J. J., Wienke, J., Anderson, J., & Giuliani, S. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03573-0 · Cited by 1
Myelomonocytic Subsets in Tumor Microenvironment
Ginderachter, J. A. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_19 · Cited by 1
Macrophage Differentiation and Activation States in the Tumor Microenvironment
Ginderachter, J. A. V. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_17 · Cited by 1
He, C., Guo, Z., Zhang, H., Yang, G., Gao, J., & Mo, Z. (2024) · Aging · doi:10.18632/aging.205454 · Cited by 1
Functions of Diverse Myeloid Cells in the Tumor Micro-Environment
Allavena, P., & Sic, A. (2012) · InTech eBooks · doi:10.5772/35123
ROLE OF THE ANG-TIE2 PATHWAY IN THE INVASIVE RECURRENCE OF GBM FOLLOWING ANTI-VEGF THERAPY
Cortes‐Santiago, N. (2014) · Digital Commons-TMC (Texas Medical Center)
Krausz, S. (2013) · UvA-DARE (University of Amsterdam)
The role of myeloid cells in breast cancer metastasis
Swierczak, A. (2012) · Minerva Access (University of Melbourne) · Cited by 1
García, S., Krausz, S., Ambarus, C. A., Fernandez, B. M., Baeten, D., Tak, P. P., & Reedquist, K. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-eular.69
Das Tumorstroma und seine Bedeutung für die Therapie solider Tumoren
Hacker, U. T. (2016) · Forum · doi:10.1007/s12312-016-0060-6 · Cited by 1
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_186-1
Monocyty z ekspresją Tie-2 u chorych na przewlekłą białaczkę limfocytową
Bojarska-Junak, A. A., Grundszok, P., Waldowska, M., Woś, J., Chocholska, S., Hus, I., Kowalska, W., Gęca, K., Tomczak, W., & Roliński, J. (2016) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2016.08.001
Examining the effects of macrophage populations on cancerous tumor growth.
Mahlbacher, G. E. (2017) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2816
Metadata
- Authors
- Coffelt, S. B., Chen, Y.-Y., Muthana, M., Welford, A. F., Tal, A. O., Scholz, A., Plate, K. H., Reiss, Y., Murdoch, C., De Palma, M., & Lewis, C. E.
- Affiliations
- University of Sheffield (GB)
- Goethe University Frankfurt (DE)
- Angiogenesis and Tumor Targeting Research Unit, San Raffaele-Telethon Institute for Gene Therapy, San Raffaele Scientific Institute , 20132 Milan ,
- Corresponding author
- Muthana, Munitta
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-01
- Volume
- 186
- Issue
- 7
- Pages
- 4183-4190
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2157483153
- Cited by
- 220
- References
- 32
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 15 · 2022: 17 · 2021: 17 · 2020: 23 · 2019: 20 · 2018: 13 · 2017: 8 · 2016: 19 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 14
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Breast Cancer Campaign
- Deutsche Forschungsgemeinschaft (project C1), SFB‐TR23)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- angiopoietin-2, Tie2-expressing monocytes, regulatory T cells, T cell activation suppression, tumor immunosuppression, IL-10, CCL17, tumor angiogenesis, myeloid cells, CD4/CD8 ratio, Foxp3, tumor-associated macrophages
- MeSH terms
- Animals, Cell Differentiation, DNA-Binding Proteins, Growth Inhibitors, Humans, Lymphocyte Activation, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Transgenic, Monocytes, Neovascularization, Pathologic, Repressor Proteins, Transcription Factors, Interleukin-10, Cell Cycle Proteins, Carcinoma, Lewis Lung, Coculture Techniques, Angiopoietin-2, Cell Line, Tumor, T-Lymphocytes, Regulatory, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.